Back to Agenda
SESSION 5: RECAP
Session Chair(s)
Kerry Gordon
Senior Director, Biostatistics, Japan, China, Europe and North America
IQVIA, United Kingdom
James Matcham
Head, Early Clinical Development Biometrics
AstraZeneca, United Kingdom
The objective of this session is to review what we have learned so far.
- Statistics as an art and science
- Sampling and variability
- Confidence interval
- Types of trial objectives
- Statistical sense
- Caution when using statistical terms
Have an account?